Optimum use of diuretics in managing ascites in patients with cirrhosis

Gut

Volumn 59, Issue 1, 2010, Pages 10-11

  Bernardi, Mauro ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANRENOATE POTASSIUM; DIURETIC AGENT; FUROSEMIDE; MINERALOCORTICOID ANTAGONIST; SPIRONOLACTONE;

ADD ON THERAPY; ASCITES; DRUG EFFICACY; DRUG MEGADOSE; GLOMERULUS FILTRATION RATE; GYNECOMASTIA; HUMAN; HYPERALDOSTERONISM; HYPERKALEMIA; HYPOVOLEMIA; KIDNEY PERFUSION; LIVER CIRRHOSIS; MONOTHERAPY; NATRIURESIS; NOTE; PORTAL HYPERTENSION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SODIUM RETENTION; WATER RETENTION;

ASCITES; DIURETICS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; LIVER CIRRHOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 73449135177     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.189506     Document Type: Note

References (10)

1. Ginés P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;7:122-8.
2. Schrier RW, Arroyo V, Bernardi M, et al. "Peripheral vasodilation hypothesis": a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-7.
3. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003;38:258-66.
4. Runyon BA. Care of patients with ascites. N Engl J Med 1994;30:337-42.
5. Fernández-Esparrach G, Guevara M, Sort P, et al. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo. J Hepatol 1997;26:614-20.
6. Pérez-Ayuso RM, Arroyo V, Planas R, et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the reninaldosterone system. Gastroenterology 1983;84:961-8.
7. Bernardi M, Laffi G, Salvagnini M, et al. Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. Liver 1993;13:156-62.
8. Fogel MR, Sawhney VK, Neal EA, et al. Diuresis in the ascitic patient: a randomized controlled trial of three regimens. J Clin Gastroenterol 1981;3(suppl 1):73-80.
9. Santos J, Planas R, Pardo A, et al. Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety. J Hepatol 2003;39:187-92.
10. Angeli P, Fasolato S, Mazza E, et al. Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial. Gut 2010;59:98-104.